SG43798A1 - Agonists and antagonistis of human interleukin-10 - Google Patents

Agonists and antagonistis of human interleukin-10

Info

Publication number: SG43798A1
Authority: SG; Singapore
Prior art keywords: antagonistis; agonists; human interleukin; interleukin; human
Prior art date: 1993-07-26

Application number

SG1996000969A

Inventor

Chuan-Chu Chou

Xiao-Yan Cai

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-26

Filing date

1994-07-22

Publication date

1997-11-14

1994-07-22 Application filed by Schering Corp filed Critical Schering Corp

1997-11-14 Publication of SG43798A1 publication Critical patent/SG43798A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

SG1996000969A 1993-07-26 1994-07-22 Agonists and antagonistis of human interleukin-10 SG43798A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9894393A	1993-07-26	1993-07-26

Publications (1)

Publication Number	Publication Date
SG43798A1 true SG43798A1 (en)	1997-11-14

Family

ID=22271670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996000969A SG43798A1 (en)	1993-07-26	1994-07-22	Agonists and antagonistis of human interleukin-10

Country Status (17)

Country	Link
EP (1)	EP0711346A1 (en)
JP (1)	JPH08507930A (en)
KR (1)	KR960704041A (en)
CN (1)	CN1127529A (en)
AU (1)	AU681178B2 (en)
CA (1)	CA2168110A1 (en)
CZ (1)	CZ23396A3 (en)
FI (1)	FI960353A (en)
HU (1)	HUT73463A (en)
IL (1)	IL110413A0 (en)
NO (1)	NO960309L (en)
NZ (1)	NZ269663A (en)
PL (1)	PL312718A1 (en)
SG (1)	SG43798A1 (en)
SK (2)	SK150596A3 (en)
WO (1)	WO1995003411A1 (en)
ZA (1)	ZA945434B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU686816B2 (en)	1994-07-05	1998-02-12	Steeno Research Group A/S	Immunomodulators
GB2304047A (en)	1995-08-09	1997-03-12	Univ Manchester	Pharmaceutical compositions containing cytokines
AUPN481295A0 (en) *	1995-08-16	1995-09-07	Medvet Science Pty. Ltd.	Agonists of haemopoietic growth factors
AU4385696A (en)	1996-01-18	1997-08-11	Christian Gronhoj Larsen	Synthetic il-10 analogues
DE19851675A1 (en) *	1998-11-10	2000-05-11	Bayer Ag	Human interleukin-10 mutant proteins
MXPA02009626A (en)	2000-03-31	2003-05-14	Idec Pharma Corp	Combined use of anti cytokine antibodies or antagonists and anti cd20 for the treatment of b cell lymphoma.
EP2295450B1 (en)	2000-09-29	2015-01-28	Merck Sharp & Dohme Corp.	Pegylated interleukin-10
US7261882B2 (en)	2003-06-23	2007-08-28	Reagents Of The University Of Colorado	Methods for treating neuropathic pain by administering IL-10 polypeptides
EP1712241A1 (en)	2005-04-15	2006-10-18	Centre National De La Recherche Scientifique (Cnrs)	Composition for treating cancer adapted for intra-tumoral administration and uses thereof
ES2696824T3 (en)	2005-05-31	2019-01-18	Univ Colorado Regents	Methods to supply genes
EP2468293B1 (en)	2006-09-28	2014-10-22	Merck Sharp & Dohme Corp.	Use of pegylated il-10 to prevent metastasis of a cancer or tumor to the lung
CN102227447A (en)	2008-10-02	2011-10-26	新兴产品开发西雅图有限公司	Cd86 antagonist multi-target binding proteins
CN102256625B (en)	2008-12-17	2013-11-20	默沙东公司	Mono- and di-peg il-10 production
ES2683844T3 (en)	2011-11-08	2018-09-28	Umc Utrecht Holding B.V.	Fusion protein comprising an interleukin 4 and interleukin 10
WO2014172392A1 (en)	2013-04-18	2014-10-23	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
WO2014176373A2 (en) *	2013-04-24	2014-10-30	Armo Biosciences, Inc.	Interleukin-10 compositions and uses thereof
ES2688206T3 (en)	2013-06-17	2018-10-31	Armo Biosciences, Inc.	Procedure for assessing protein identity and stability
CA2920679A1 (en)	2013-08-30	2015-03-05	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
RU2016122957A (en)	2013-11-11	2017-12-19	Армо Байосайенсиз, Инк.	Methods of using interleukin-10 for the treatment of diseases and disorders
WO2015187295A2 (en)	2014-06-02	2015-12-10	Armo Biosciences, Inc.	Methods of lowering serum cholesterol
MX2017004838A (en)	2014-10-14	2017-10-16	Armo Biosciences Inc	Interleukin-15 compositions and uses thereof.
WO2016064817A1 (en)	2014-10-22	2016-04-28	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en)	2015-02-03	2020-04-14	Armo Biosciences, Inc.	Method of treating cancer with IL-10 and antibodies that induce ADCC
CA2986755A1 (en)	2015-05-28	2016-12-01	Armo Biosciences, Inc.	Pegylated interleukin-10 for use in treating cancer
CN108025040A (en)	2015-08-25	2018-05-11	阿尔莫生物科技股份有限公司	The method that disease and illness are treated using interleukin-10
AU2020258026A1 (en)	2019-04-19	2021-11-11	Synerkine Pharma B.V.	A fusion protein comprising IL13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01113229A (en) *	1987-10-27	1989-05-01	Inahata Kenkyusho:Kk	Porous material of honeycomb structure
IL94878A (en) *	1989-06-28	2003-01-12	Schering Corp	Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
WO1993002693A2 (en) *	1991-08-06	1993-02-18	Schering Corporation	Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity

1994
- 1994-07-22 SG SG1996000969A patent/SG43798A1/en unknown
- 1994-07-22 CA CA002168110A patent/CA2168110A1/en not_active Abandoned
- 1994-07-22 KR KR1019960700358A patent/KR960704041A/en not_active Application Discontinuation
- 1994-07-22 SK SK1505-96A patent/SK150596A3/en unknown
- 1994-07-22 NZ NZ269663A patent/NZ269663A/en unknown
- 1994-07-22 EP EP94923956A patent/EP0711346A1/en not_active Withdrawn
- 1994-07-22 HU HU9503983A patent/HUT73463A/en unknown
- 1994-07-22 AU AU73996/94A patent/AU681178B2/en not_active Ceased
- 1994-07-22 SK SK83-96A patent/SK8396A3/en unknown
- 1994-07-22 JP JP7505238A patent/JPH08507930A/en active Pending
- 1994-07-22 WO PCT/US1994/008052 patent/WO1995003411A1/en not_active Application Discontinuation
- 1994-07-22 ZA ZA945434A patent/ZA945434B/en unknown
- 1994-07-22 PL PL94312718A patent/PL312718A1/en unknown
- 1994-07-22 CZ CZ96233A patent/CZ23396A3/en unknown
- 1994-07-22 CN CN94192880A patent/CN1127529A/en active Pending
- 1994-07-22 IL IL11041394A patent/IL110413A0/en unknown
1996
- 1996-01-25 NO NO960309A patent/NO960309L/en unknown
- 1996-01-26 FI FI960353A patent/FI960353A/en unknown

Also Published As

Publication number	Publication date
IL110413A0 (en)	1994-10-21
WO1995003411A1 (en)	1995-02-02
HUT73463A (en)	1996-08-28
PL312718A1 (en)	1996-05-13
CA2168110A1 (en)	1995-02-02
FI960353A0 (en)	1996-01-26
EP0711346A1 (en)	1996-05-15
JPH08507930A (en)	1996-08-27
FI960353A (en)	1996-01-26
NZ269663A (en)	1997-09-22
CZ23396A3 (en)	1996-05-15
KR960704041A (en)	1996-08-31
ZA945434B (en)	1995-01-23
CN1127529A (en)	1996-07-24
NO960309D0 (en)	1996-01-25
SK150596A3 (en)	1997-04-09
SK8396A3 (en)	1997-03-05
NO960309L (en)	1996-01-25
AU7399694A (en)	1995-02-20
AU681178B2 (en)	1997-08-21
HU9503983D0 (en)	1996-03-28

Publication	Publication Date	Title
SG43798A1 (en)	1997-11-14	Agonists and antagonistis of human interleukin-10
GB9214857D0 (en)	1992-08-26	Human nucleic acid fragments and their use
GB9300213D0 (en)	1993-03-03	Wrist and hand support
EP0880356A4 (en)	2002-03-27	Antimicrobial peptides and methods of use
GB2277826B (en)	1995-03-01	Surgical and/or clinical apparatus
HU9502586D0 (en)	1995-10-30	Purification of human interleukin-10
HU9403655D0 (en)	1995-02-28	Methods of inhibiting atrophy of the skin and vagina
EP0586687A4 (en)	1996-04-17	Trans-sialidase and methods of use and making thereof
IL114331A0 (en)	1995-10-31	Medical use of bromelain
EP0729300A4 (en)	1998-08-05	Novel fas protein and methods of use thereof
HU9600241D0 (en)	1996-03-28	Mutable composition and methods of use thereof
HU9402361D0 (en)	1994-10-28	New makrolides and use of them
GB9219425D0 (en)	1992-10-28	Therapeutic agent and its use
ZA899778B (en)	1990-09-26	Reduction of piperidine-dion-derivatives and intermediates
SG42309A1 (en)	1997-08-15	Medical use of enzymes
GB2294637B (en)	1997-11-12	Therapeutic compositions and methods of use
HUP9800146A3 (en)	2000-06-28	Thalidomide-derivatives and use of them
GB2275314B (en)	1996-04-10	Support member and method of use
EP1015559A4 (en)	2002-11-06	Human regeneration-associated serpin-1 (rasp-1) and methods of use
GB9318480D0 (en)	1993-10-20	Briquette and preparation of same
GB9312030D0 (en)	1993-07-28	Preparation and use of lipo-n-acetyl-cysteine
GB9308018D0 (en)	1993-06-02	Connecting means and method of use thereof
GB9213862D0 (en)	1992-08-12	Medical use of enzymes
GB9318914D0 (en)	1993-10-27	Preparation of fluoro-nucleosides and intermediates for use therein
GB9308164D0 (en)	1993-06-02	Medical use of enzymes